Noninvasive Body Contouring: Selection Criteria for the Appropriate Technique
SKIN: The Journal of Cutaneous Medicine(TM), Noninvasive body contouring: Literature Review and Summary of Objective Data
This [study] enables the selection of a body contouring modality that best suits each specific patient’s goals, availability and aversion to risk”
NEW YORK, NEW YORK, USA, July 5, 2017 /EINPresswire.com/ -- Noninvasive body contouring is an increasingly popular cosmetic procedure that allows patients to get rid of excess fat without undergoing surgery. Until now, objective studies comparing modalities have been limited, making it difficult for both the physician and patient to optimally choose the approach that will work best for them.— Daniel Bernstein, M.D.
A new article published today in SKIN: The Journal of Cutaneous Medicine(TM) summarizes objective data on noninvasive body contouring between the four most common modalities: cryolipolysis, focused ultrasound, radiofrequency, and low level laser therapy.
Daniel Bernstein, M.D., of the Icahn School of Medicine at Mount Sinai Department of Dermatology and coauthors examined 55 articles and reported data from 3649 patients to show that the best reported positive results have been obtained with radiofrequency. In addition, the most common and significant side effects were with cryolipolysis and absent with low level laser therapy. The study found that in general “… the modalities with the least risky side effect profiles were associated with the most modest reductions in localized fat.”
“This [study] enables the selection of a body contouring modality that best suits each specific patient’s goals, availability and aversion to risk” according to Bernstein and co-authors.
SKIN: The Journal of Cutaneous Medicine(TM) is a peer-reviewed online medical journal that is the official journal of The National Society for Cutaneous Medicine. The mission of SKIN is to provide an enhanced and accelerated route to disseminate new dermatologic knowledge for all aspects of cutaneous disease.
For more details please visit www.jofskin.org or contact jofskin@gmail.com.
Editors Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Link to article
(DOI: 10.25251/skin.1.1.4)
Daniel Bernstein, M.D.
Icahn School of Medicine at Mount Sinai
bernstd@gmail.com
email us here
